FTLF at a glance
FITLIFE BRANDS, INC. (FTLF, SEC CIK 1374328) filed its latest 10-K annual report on March 31, 2026, a 10-Q quarterly report on August 13, 2026, an 8-K current report on September 9, 2026 and Form 4 insider filings as recently as September 2, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- For the fiscal year ended December 31, 2025 (FY2025), FITLIFE BRANDS, INC. (FTLF) reported revenue of $81.5 million (up 26.4% from FY2024) and net income of $6.3 million. Diluted EPS was $0.63.
- As of June 30, 2026, 10 institutional investment managers tracked by SignalX reported holding FITLIFE BRANDS, INC. (FTLF) shares worth $2.9 million in 13F-HR filings.
- The most recent insider open-market purchase reported on Form 4 was by Pappas Shannon K. on August 19, 2026 of 1,000 shares at $10.25 per share.
- In the last 90 days, FTLF insiders reported 1 open-market purchase ($10K) and 0 open-market sales ($0) on Form 4, a net purchase of $10K.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Revenue · FY2025
- $81.5M
- +26.4% vs prior year
- Insiders · 90 days
- 1 buy · 0 sells
- Net +$10K
- 13F holders
- 10 funds
- $2.9M · −2 vs prior quarter
- Latest 8-K
- Sep 9, 2026
- Item 7.01
AI 10-Q Quarterly Report Analysis
Latest 10-Q, quarter ended Jun 30, 2026
Management Discussion & Analysis
- Q2 revenue $26,549, up 65% YoY from $16,127, driven by Irwin acquisition
- Gross margin 37.0% vs 42.8% YoY; net income $1,950 vs $1,747
- Best performer Irwin revenue $14,135; Legacy FitLife revenue $12,414, down 23% YoY
- Cash $1,089; operating cash flow $6,119 vs $3,523 YoY
- Debt repayments drove financing cash use of $6,647 vs $1,568; liquidity expected sufficient for next twelve months
Risk Factors
- No material changes to risk factors from the December 31, 2025 Form 10-K
- Carried-forward risks remain capable of negatively impacting business, financial condition, and future prospects
- No new regulatory, legal, compliance, operational, competitive, market, or financial risk identified this quarter
AI summary of the FTLF 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K
AI 8-K Current Report Analysis
The most recent material events, by 8-K item
Item 7.01: Regulation FD Disclosure
- New corporate presentation adopted September 9, 2026 for business purposes
- Exhibit 99.1 contains management’s current investor and business messaging
Item 2.02: Results of Operations and Financial Condition
- Item 2.02 provides no operating results or financial figures in the supplied text
- Disclosure appears limited to the press release’s non-incorporation status under federal securities laws
Item 5.07: Submission of Matters to a Vote of Security Holders
- All five director nominees elected through 2027 annual meeting, preserving board continuity
- Dayton Judd received 6,473,347 votes for and 7,871 withheld, the strongest director support
Item 5.02: Departure/Appointment of Directors or Principal Officers
- Ryan Hansen promoted from Executive Vice President to President effective May 18, 2026
- Base salary increased from $275,000 to $300,000
AI summaries of FTLF 8-K current reports filed with the SEC. What 8-K item codes mean
SignalX for FTLF
Don't miss the next FTLF filing
- Alerts as it files. A push when FTLF files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut FTLF, by share count.
- Ask anything. An AI agent that reads every FTLF filing and answers with sources.
FTLF alerts on your phone. Follow it in the SignalX Android app.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| York Jakob | A | Aug 28, 2026 | 4,000 | - |
| Pappas Shannon K. | Buy | Aug 19, 2026 | 1,000 | $10.25 |
| Hansen Ryan P. | A | May 15, 2026 | 28,500 | - |
| Hansen Ryan P. | A | May 15, 2026 | 46,500 | - |
| Hansen Ryan P. | A | May 15, 2026 | 50,000 | - |
| Lingenbrink Matthew | Buy | Apr 10, 2026 | 3,000 | $9.76 |
| Dawson Grant Robert | Buy | Apr 10, 2026 | 3,000 | $9.98 |
| Yakatan Seth | Buy | Jan 15, 2026 | 164 | $15.36 |
Financial SummaryXBRL
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Profitability | |||
| Revenue | - | $64.5M | $81.5M |
| Gross Profit | - | $28.1M | $31.5M |
| Operating Income | - | $13.1M | $10.1M |
| Net Income | - | $9.0M | $6.3M |
| Gross Margin | - | 43.6% | 38.6% |
| Op. Margin | - | 20.3% | 12.4% |
| Net Margin | - | 13.9% | 7.8% |
| Balance Sheet | |||
| Total Assets | $55.3M | $58.5M | $106.3M |
| Equity | - | $36.1M | $43.6M |
| ROE | - | 24.9% | 14.5% |
| Per Share | |||
| EPS | $1.08 | $0.91 | $0.63 |
| Cash Flow | |||
| Operating CF | - | $9.6M | $7.4M |
| CapEx | - | $10K | $42K |
Source: XBRL data in FITLIFE BRANDS, INC. (FTLF)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →
13F Fund Holdings: Quarterly Trend
Latest: Q2 2026Aggregate FTLF share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q2 2026 | 10 | $2.9M |
| Q1 2026 | 12 | $6.4M |
| Q4 2025 | 13 | $8.2M |
| Q3 2025 | 11 | $9.7M |
| Q2 2025 | 12 | $6.1M |
| Q1 2025 | 8 | $2.2M |
- BlackRock−122.1K (-78%)
- Northern Trust−42.9K (-80%)
- State Street Corp−24.0K (-60%)
- Dimensional Fund Advisors−6.7K (-39%)
- Morgan Stanley−891 (-47%)
- Millennium Management+23.5K
- Goldman Sachs Group+15.3K
- Vanguard Portfolio Management LLC−23.5K
- JPMorgan Chase & Co−1.6K
- Wells Fargo & Co−1.4K
- Citigroup−205
Source: 13F-HR filings on SEC EDGAR (aggregated from 66 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
FTLF filing archive
AI analysis pages for each 10-K, 10-Q and 8-K
10-K annual reports
10-Q quarterly reports
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 8-K | Sep 9, 2026 | - | Analysis | - |
| 4 | Sep 2, 2026 | - | - | - |
| 4 | Aug 21, 2026 | - | - | - |
| 8-K | Aug 13, 2026 | - | Analysis | - |
| 10-Q | Aug 13, 2026 | Jun 30, 2026 | Analysis | |
| 8-K | May 22, 2026 | - | Analysis | |
| 4 | May 19, 2026 | - | - | |
| 8-K | May 14, 2026 | - | Analysis | |
| 10-Q | May 14, 2026 | Mar 31, 2026 | Analysis | |
| 4 | Apr 20, 2026 | - | - | - |
| 4 | Apr 14, 2026 | - | - | - |
| 4 | Apr 14, 2026 | - | - | - |
| 8-K | Apr 7, 2026 | - | Analysis | - |
| 8-K | Apr 1, 2026 | - | - | - |
| 10-K | Mar 31, 2026 | Dec 31, 2025 | - | |
| 8-K | Dec 10, 2025 | - | - | |
| 10-Q | Nov 13, 2025 | Sep 30, 2025 | Analysis | |
| 10-Q | Aug 14, 2025 | Jun 30, 2025 | - | |
| 10-Q | May 15, 2025 | Mar 31, 2025 | - | |
| 10-K | Mar 27, 2025 | Dec 31, 2024 | Analysis | |
| SC 13G | Jan 17, 2025 | - | - | |
| 10-Q | Nov 14, 2024 | Sep 30, 2024 | - | |
| 10-Q | Aug 14, 2024 | Jun 30, 2024 | - | |
| 10-Q | May 14, 2024 | Mar 31, 2024 | - | |
| 10-K | Mar 29, 2024 | Dec 31, 2023 | - |
Related Health Care companies
- BTMD · biote Corp.Medicinal Chemicals & Botanical Products
- DFTX · Definium Therapeutics, Inc.Medicinal Chemicals & Botanical Products
- MDWD · MediWound Ltd.Medicinal Chemicals & Botanical Products
- NAGE · Niagen Bioscience, Inc.Medicinal Chemicals & Botanical Products
- USNA · USANA HEALTH SCIENCES INCMedicinal Chemicals & Botanical Products
- TXG · 10x Genomics, Inc.Laboratory Analytical Instruments
- FDMT · 4D Molecular Therapeutics, Inc.Biological Products, (No Diagnostic Substances)
- AARD · Aardvark Therapeutics, Inc.Pharmaceutical Preparations
FTLF SEC filings: frequently asked questions
Are FTLF insiders buying or selling?
In the last 90 days, FITLIFE BRANDS, INC. (FTLF) officers, directors and 10% owners reported 1 open-market purchase worth $10,250 by 1 insider and no open-market sales on Form 4. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.
Which institutions hold FTLF stock?
As of June 30, 2026, the largest FITLIFE BRANDS, INC. (FTLF) holders among the 13F filers tracked by SignalX were Vanguard Capital Management LLC ($1.7 million), BlackRock ($389,000), Millennium Management ($258,000), State Street Corp ($180,000), Goldman Sachs Group ($168,000). 13F-HR reports are filed up to 45 days after each quarter ends.
What was FTLF's revenue in fiscal year 2025?
For the fiscal year ended December 31, 2025 (FY2025), FITLIFE BRANDS, INC. (FTLF) reported revenue of $81.5 million (up 26.4% from FY2024) and net income of $6.3 million. Diluted EPS was $0.63. The figures come from the XBRL data in the 10-K.
What did FTLF report in its latest 8-K?
FITLIFE BRANDS, INC. (FTLF) filed an 8-K on September 9, 2026 reporting Item 7.01 (Regulation FD Disclosure). New corporate presentation adopted September 9, 2026 for business purposes.
What are the latest FTLF SEC filings?
FITLIFE BRANDS, INC. (FTLF) filed its latest 10-K annual report on March 31, 2026, a 10-Q quarterly report on August 13, 2026, an 8-K current report on September 9, 2026 and a Form 4 insider filing on September 2, 2026.
What is FTLF's SEC CIK number?
FITLIFE BRANDS, INC. (FTLF)'s SEC Central Index Key (CIK) is 1374328. EDGAR lists every FTLF filing under that number.
Ask anything about FTLF
The research agent reads FTLF's filings, financials, insider trades and 13F holders, then answers with sources.